Palbociclib Impurity A-d4 is the deuterated form of Palbociclib Impurity A (P139940) which is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Also, it is derived from 3-Fluoro-2-nitropyridine (F597685). Molecular Formula: C24H25D4N7O2 Molecular Weight: 451.56 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
451.56
* VAT and and shipping costs not included. Errors and price changes excepted
